Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of oliceridine for postoperative analgesia in children after laparoscopic hernia repair
ChiCTR2500111172Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine in inguinal hernia (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: ED90 of oliceridine for postoperative analgesia. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on ChiCTR2500111172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111172.